Global Cell & Gene Therapy Drug Delivery Devices Market:...

Global Cell & Gene Therapy Drug Delivery Devices Market: Expanding at a CAGR of more than 14% during 2023-2028

Posté 2024-09-18 12:27:23

4KB

Market Insights

As per recent research by MarkNtel Advisors, The Global Cell & Gene Therapy Drug Delivery Devices Market is projected to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28.

“In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

Key Drivers: The factors that are projected to drive the market in the coming years include the following:

Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies
Mounting prevalence of genetic disorders & chronic diseases
An increasing number of FDA approvals for cell & gene therapies & their clinical trials

Market Segmentation and Consumer Behavior:

By Product Type
- Sub-retinal Injection Cannula
- Extension Tube
- Intravenous Catheter
- Sterile Insulin Syringe
  - Size 1.0 ML, 31-Gauge Needle
  - Size 0.5 ML, 22-Gauge Needle
- Pre-Filled Syringe
  - Size 1.0 ML, 22-26 Gauge Needle
  - Size 4.0 ML, 22-26 Gauge Needle
- Infusion Bags
  - Infusion Bags (Size 10 ML to 50 ML)
  - Infusion Bags (Size 68 ML)
  - Infusion Bags (Size 60 ML)
  - Infusion Bags (Size Up to 65 ML)
- By Technology
  - Microchip Technology
  - Nano-Technology
  - Lipid Nanoparticles
- By Commercialized Drugs
  - Luxturna
  - Kymriah
  - Yescarta
  - Zolgensma
  - Provenge
  - Strimvelis
- By End-User
  - Pharmaceuticals & Biotechnology Company
  - Academic & Research Institute
  - Hospitals & Clinics

Read Full Report: https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Cell & Gene Therapy Drug Delivery Devices Market Geographical Analysis:

By Region:

North America
South America
Europe
Middle East and Africa
Asia-Pacific

Key Players and Competitive Strategies in the Cell & Gene Therapy Drug Delivery Devices Market

Several prominent players dominate the Cell & Gene Therapy Drug Delivery Devices Market, including:

Amgen Inc.
Bausch & Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio Inc.
Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
Dendreon Pharmaceuticals LLC
Helixmith Co. Ltd (ViroMed Co., Ltd)
Human Stem Cells Institute
Kite Pharma Inc.
Kolon TissueGene, Inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer Inc.
Renova Therapeutics
Spark Therapeutics Inc.
uniQure N.V.
Vericel Corporation

Report Delivery - MarkNtel Advisors offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

1.What factors are driving the Cell & Gene Therapy Drug Delivery Devices Market growth?

2.How is the Cell & Gene Therapy Drug Delivery Devices Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Cell & Gene Therapy Drug Delivery Devices Market?

4.What is the current size of the Cell & Gene Therapy Drug Delivery Devices Market, and how is it projected to change in the future?

5.What is the future outlook for the Cell & Gene Therapy Drug Delivery Devices Market in terms of technological advancements and market expansion?

Request Customization - https://www.marknteladvisors.com/query/request-customization/cell-gene-therapy-drug-delivery-devices-market.html

Read Blog:

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.